Evidence map›Paper›PMID 42865865›Full record

ReviewInternational journal of nanomedicine2026

Bone Extracellular Matrix-Inspired Biomaterials for Enhanced Bone Repair.

Shouye Sun, Chuangang Peng, Yuhang Tian, Dankai Wu, Yutao Cui

Abstract readReview
In one paragraph

Review in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shouye SunOrthopaedic Medical Center, The Second Hospital of Jilin University, Changchun, 130041, People's Republic of China.
Chuangang PengOrthopaedic Medical Center, The Second Hospital of Jilin University, Changchun, 130041, People's Republic of China.
Yuhang TianOrthopaedic Medical Center, The Second Hospital of Jilin University, Changchun, 130041, People's Republic of China.
Dankai WuOrthopaedic Medical Center, The Second Hospital of Jilin University, Changchun, 130041, People's Republic of China.
Yutao CuiDepartment of Orthopedics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treatment of critical-sized large bone defects arising from severe trauma, tumor resection, infectious osteomyelitis and congenital skeletal malformations has long been a prominent and intractable clinical challenge in orthopedic surgery. Conventional autologous and allogeneic bone grafts suffer from unavoidable limitations including donor site complications, insufficient bone volume and immune rejection, driving urgent demands for advanced artificial bone repair materials. Functionalized bone substitute biomaterials capable of stimulating mesenchymal stem cell osteogenic differentiation and remarkably improving local bone regeneration efficiency represent a promising therapeutic candidate to overcome existing clinical bottlenecks. The native extracellular matrix (ECM) constructs a dynamic, hierarchically structured and biochemically complex microenvironment to sustain diverse cellular physiological behaviors. It delivers synergistic biochemical signaling and biomechanical stimuli to directly or indirectly modulate cell proliferation, adhesion, migration and lineage differentiation, thus exerting an irreplaceable regulatory function in sustaining bone metabolic homeostasis and orchestrating the whole cascade of bone regeneration. As researchers gain deeper understanding of the unique biological functions and underlying molecular signaling mechanisms of ECM constituents in bone defect reconstruction, ECM-mimicking biomaterials have garnered tremendous research interest in regenerative medicine. By precisely recapitulating native bone's chemical composition, porous microstructure and mechanical characteristics via delicate biomimetic engineering, such biomaterials successfully reproduce the physiological cascade of bone repair and achieve satisfying regenerative outcomes across abundant in vitro and preclinical in vivo investigations. This review systematically elaborates the multifaceted biological roles and core molecular mechanisms of ECM during bone reconstruction, thoroughly summarizes state-of-the-art fabrication and functional modification strategies of ECM-inspired biomaterials, as well as their repair performance against critical-sized bone defects. It intends to offer integrated theoretical foundations and innovative design guidelines for the exploitation of high-performance bone graft substitutes for clinical bone defect treatment.

Indexed as

Biocompatible MaterialsBiomimetic MaterialsBone RegenerationBone SubstitutesExtracellular MatrixAnimalsHumansMesenchymal Stem CellsOsteogenesisBiocompatible MaterialsBone Substitutesbiomimetic designbone defect repairextracellular matrixfunctionalized bone substitutesosteogenic differentiation

Identifiers

PMID42865865
PMCPMC13656001

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.